DTMT NETWORK

Healthspring, which operates a network of primary care clinics in different Indian cities, has received approval from the designated authorities in Pune and Mumbai to start testing for detecting coronavirus antibodies. It may be noted that Mumbai and Pune are worst Covid-affected cities in Maharashtra.

The tests will be available at 15 clinics of Healthspring in Mumbai and Pune. Each test will cost Rs 1250. These tests are suited for high risk groups like immuno-compromised patients, individuals in containment zones, health care workers, amongst others from the essential services group. The test has the specificity greater than 99.8% and sensitivity is of 100% (14 days post-PCR confirmation).

The test is a uniquely designed, high quality serology test for identification of antibodies developed in a person’s body. These antibodies indicate that the individuals may have had Covid-19 in the past and has developed antibodies that protects them from reinfection.

Mr. Kaushik Sen, Co-founder and CEO, Healthspring, said, “These rapid antibody testing kits are of world-class standards. They are already deployed in countries like UK, Singapore, etc. This is a revolutionary step taken by the authorities as the results, along with other information, will help the health care provider make an informed recommendation about patient care.

“This lab-based testing process is being conducted only through NABL certified labs like Healthspring. It will be beneficial to those individuals who have been exposed to the virus or if they live in or have recently traveled to a place where transmission of COVID-19 is known to occur,” added Mr Sen.